↓ Skip to main content

A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol

Overview of attention for article published in Trials, March 2023
Altmetric Badge

Mentioned by

twitter
7 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
12 Mendeley